MedTrace Logo

CAR-T Cells Targeting Autoimmune Diseases

NCT05459870 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-07-19

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility, safety and efficacy of CAR-T cell therapy in patients with autoimmune disease. Another goal of the study is to learn more about the safety and function of the CAR-T cells and their persistency in autoimmune disease patients.

Conditions

Interventions

BIOLOGICAL

4SCAR T cells

Infusion of 4SCAR T cells at 10\^6 cells/kg body weight via IV

Sponsors & Collaborators

  • Guilin Hospital of Chinese Traditional and Western Medicine

    collaborator UNKNOWN

  • Shenzhen Geno-Immune Medical Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2025-07-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459870 on ClinicalTrials.gov